Pharmaceutical composition

Patent 4879287 Issued on November 7, 1989. Estimated Expiration Date:

December 21, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

3178345

Process for the production of base for topical steroids
Patent #: 4013792
Issued on: 03/22/1977
Inventor: Eichman , et al.

Topical and other type pharmaceutical formulations containing isosorbide carrier
Patent #: 4082881
Issued on: 04/04/1978
Inventor: Chen, et al.

Ophthalmic drug delivery system utilizing thermosetting gels
Patent #: 4474751
Issued on: 10/02/1984
Inventor: Haslam , et al.

Pharmaceutical formulations containing pseudomonic acid
Patent #: 4524075
Issued on: 06/18/1985
Inventor: Oduro-Yeboah

Pharmaceutical gel composition Patent #: 4604384
Issued on: 08/05/1986
Inventor: Smith , et al.

Inventors

Assignee

Beecham Group p.l.c.

Application

No. 288023 filed on 12/21/1988

US Classes:

514/171With additional active ingredient

Examiners

Primary: Terapane, John F.
Assistant: Wolffe, Susan

Attorney, Agent or Firm

Jacobs & Jacobs

Foreign Patent References

128338 EP. 12/13/1984
167856 EP. 01/13/1986
851470 GR. 11/13/1985
3756 PE. 11/13/1985
894424 GB 04/13/1962
1395907 GB. 05/13/1975
2148116 GB. 05/13/1985

International Class

A61K 031/56

Foreign Application Priority Data

1985-12-13 GB

Abstract

Pharmacuetical compositions for topical application to the skin are disclosed comprising the hydrated crystalline calcium salt of mupirocin and a corticosteriod intimately mixed therewith. The compositions are useful for the treatment of skin disorders in humans and domestic animals.

Other References

J. Wuite et al., The Lancet, Aug. 13, 1983, p. 394
Chemical Abstracts, vol. 99, No. 21, Nov. 21, 1983, p. 361, Abstract No. 172689s
Chemical Abstracts, vol. 104, No. 5, Feb. 3, 1986, p. 20, Abstract No. 28433h
R. J. Boon et al., Journal of Antimicrobial Chemotherapy, (1985), 16, 519-526
G. D. Reilly et al., Royal Society of Medicine International Congress and Symposium Series No. 80, edited by D. S. Wilkinson and J. D. Price, The Royal Society of Medicine, London (1984), pp. 73-78
C. P. Fitzsimons et al., Ibid, pp. 127-129
L. R. Lever et al., Ibid, pp. 131-136
C. R. Lovell et al., Ibid, pp. 137-140
N. B. Simpson et al., Proceedings of an International Symposium, Current Clinical Series 16, edited by R. L. Dobson et al., Excerpta Medica, Elsevier Science Publishers, Amsterdam 1985, pp. 171-176
J. D. Wilkinson et al., Ibid, pp. 177-182
C. F. H. Vickers, Round Table Series 4, edited by C. Wood, Royal Society of Medicine Services, Alden Press, Oxford 1986, pp. 32-37
General Discussion II, Ibid, pp. 38-43
J. Reid et al., Ibid, pp. 46-49
General Discussion IV, Ibid, pp. 61-68
B. I. Davies, Ibid, pp. 69-7